// App-Quantinova.ai

: Adoption of Prophylaxis in the United States in the Era of Extended Half-Life Factor Concentrates

Researchers

Presenter

  • Lynn M. Malec

Principal Investigators

  • Gilbert C. White

  • Stacy E. Croteau

  • Dunlei Cheng

  • Margaret V. Ragni

Medical Centers

  • Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI

  • Children's Hospital Boston, Boston, MA

  • American Thrombosis and Hemostasis Network, Riverwoods, IL

  • Critical Care Medicine and Clinical and Translational Science, University of Pittsburgh, Pittsburgh, PA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Hemophilia

  • Venous thrombosis

Biomarkers

  • Estrogen receptor alpha

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • American Thrombosis And Hemostasis Network (ATHN)

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved